glp-1 effectiveness A KFF analysis shows that use of and spending for drugs under Medicare grew substantially between 2019 and 2024, reflecting their in treating type 2 diabetes and other conditions. Medicare Relationship between exposure/dose, effectiveness and

Surg Obes Relat Dis 14(9):13681372 Brown AM, Yang J, Zhang X, Docimo S, Pryo AD, Spaniolas K (2022) Bariatric surgery lowers the risk of major cardiovascular events

The activation of GLP-1 receptors has become a focus in the search for effective treatments for diabetes and metabolic disorders, and it has more recently gained approval as a weight-loss treatment

It allows for sustainable weight loss, gradual dose titration, and better habit formation

*Correspondence: Riadh Ilahy [email protected] This article was submitted to Food Chemistry, a section of the journal Frontiers in Nutrition Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers